Please Cite Us As:
RRID coming soon
Publications Utilizing Our Services:
2025
Högström JM, Muranen T. An Optimized Protocol for Simultaneous Propagation of Patient-derived Organoids and Matching CAFs. Bio Protoc. 2025 Jan 20;15(2):e5160. PubMed Central PMCID: PMC11769750.
Wang Z, Li Z, Högström J, Inuzuka H, Jing R, Yan P, Hou T, Qi Y, Huang D, Wang J, Wu T, Shi X, Liu B, Muranen T, Zhang D, Wei W. Dual membrane receptor degradation via folate receptor targeting chimera. Nat Commun. 2025 Oct 2;16(1):8804. PubMed Central PMCID: PMC12491540.
2024
Hillis AL, Martin TD, Manchester HE, Högström J, Zhang N, Lecky E, Kozlova N, Lee J, Persky NS, Root DE, Brown M, Cichowski K, Elledge SJ, Muranen T, Fruman DA, Barry ST, Clohessy JG, Madsen RR, Toker A. Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer. Cancer Res. 2024 Oct 1;84(19):3250-3266. PubMed Central PMCID: PMC11443248.
2023
Hogstrom JM, Cruz KA, Selfors LM, Ward MN, Mehta TS, Kanarek N, Philips J, Dialani V, Wulf G, Collins LC, Patel JM, Muranen T. Simultaneous isolation of hormone receptor-positive breast cancer organoids and fibroblasts reveals stromamediated resistance mechanisms. J Biol Chem. 2023 Aug;299(8):105021. PubMed Central PMCID: PMC10415704.
2022
Choi BH, Rawat V, Högström J, Burns PA, Conger KO, Ozgurses ME, Patel JM, Mehta TS, Warren A, Selfors LM, Muranen T, Coloff JL. Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumors. Cell Rep. 2022 Jan 18;38(3):110278. PubMed Central PMCID: PMC8845302